50
Participants
Start Date
August 31, 2004
Primary Completion Date
August 31, 2008
bevacizumab
30-90 minutes on day 1, every 21 days up to 12 months.
capecitabine
twice daily on days 1-14. Courses repeat every 21 days for up to 12 months in the absence of disease progression or unacceptable toxicity.
gemcitabine hydrochloride
IV over 30 minutes on days 1 and 8. Courses repeat every 21 days for up to 12 months in the absence of disease progression or unacceptable toxicity.
Roswell Park Cancer Institute, Buffalo
Case Comprehensive Cancer Center, Cleveland
Roswell Park Cancer Institute
OTHER